Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Vertex Pharmaceuticals Incorpo - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
VRTX
Nasdaq
2834
https://www.vrtx.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Vertex Pharmaceuticals Incorpo
Vertex Pharmaceuticals (VRTX) Stock Falls Amid Market Uptick: What Investors Need to Know
- Apr 16th, 2024 10:00 pm
Vertex Pharma scientist talks about the long road to developing non-addictive painkillers
- Apr 15th, 2024 4:00 pm
Here's (at Least) 1 new Reason to Buy Vertex Pharmaceuticals Stock
- Apr 15th, 2024 1:15 pm
Investors Heavily Search Vertex Pharmaceuticals Incorporated (VRTX): Here is What You Need to Know
- Apr 15th, 2024 1:04 pm
3 Magnificent Stocks That Could Double or More by 2030
- Apr 13th, 2024 12:47 pm
Could This Stock Be the Next Biotech Buyout?
- Apr 13th, 2024 9:29 am
Alpine (ALPN) Surges 37% on $4.9B Buyout Offer From Vertex
- Apr 12th, 2024 4:36 pm
Health Care Roundup: Market Talk
- Apr 12th, 2024 2:55 pm
Vertex Pharmaceuticals to buy Alpine Immune Sciences in $4.9B deal
- Apr 11th, 2024 8:29 pm
Alpine Catapults 37% After Vertex Pledges $4.9 Billion To Buy It
- Apr 11th, 2024 8:18 pm
Stocks to Watch Thursday: Robinhood, Alpine Immune, Constellation Brands
- Apr 11th, 2024 5:59 pm
Vertex Pharmaceuticals Seeks a Second Act With Alpine Immune Deal. What Wall Street Says.
- Apr 11th, 2024 3:03 pm
Dow Jones Lower Despite PPI Inflation Relief; Nvidia, Microsoft Price Targets Raised
- Apr 11th, 2024 2:27 pm
The $5 BILLION Reason Alpine Immune Sciences (ALPN) Stock Is Up 30% Today
- Apr 11th, 2024 1:47 pm
These Stocks Are Moving the Most Today
- Apr 11th, 2024 1:47 pm
Vertex to Pay $4.9 Billion for Kidney Disease Drug Developer
- Apr 11th, 2024 1:39 pm
Vertex Pharmaceuticals: Buy, Sell, or Hold?
- Apr 11th, 2024 1:15 pm
US STOCKS-Futures slip as rate-cut hopes ebb
- Apr 11th, 2024 10:17 am
Vertex Pharmaceuticals (VRTX) Registers a Bigger Fall Than the Market: Important Facts to Note
- Apr 10th, 2024 10:00 pm
Vertex Pharmaceuticals to Acquire Alpine Immune Sciences for $4.9 Billion
- Apr 10th, 2024 9:47 pm
Scroll